The activation of caspase-3 by hyperhomocystenemia promotes the accumulation of amyloid on smooth muscle cells of small vessel disease (Leulliot et al., 2004; Chun et al., 2016), which leads to a dysregulation of cerebral blood flow, commonly observed in AD and in vascular dementia. Here, CASP3 is linked to amyloidosis.